- Home
- NBIX vs CART Comparison
NBIX vs CART Comparison
Compare NBIX & CART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- CART
- Stock Information
- Founded
- NBIX 1992
- CART 2012
- Country
- NBIX United States
- CART United States
- Employees
- NBIX N/A
- CART N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- CART
- Sector
- NBIX Health Care
- CART
- Exchange
- NBIX Nasdaq
- CART Nasdaq
- Market Cap
- NBIX 14.4B
- CART 12.2B
- IPO Year
- NBIX 1996
- CART 2023
- Fundamental
- Price
- NBIX $140.02
- CART $38.64
- Analyst Decision
- NBIX Strong Buy
- CART Buy
- Analyst Count
- NBIX 17
- CART 26
- Target Price
- NBIX $164.94
- CART $53.73
- AVG Volume (30 Days)
- NBIX 803.5K
- CART 7.1M
- Earning Date
- NBIX 10-28-2025
- CART 11-10-2025
- Dividend Yield
- NBIX N/A
- CART N/A
- EPS Growth
- NBIX 2.97
- CART N/A
- EPS
- NBIX 3.39
- CART 1.73
- Revenue
- NBIX $2,509,900,000.00
- CART $3,546,000,000.00
- Revenue This Year
- NBIX $20.79
- CART $12.29
- Revenue Next Year
- NBIX $14.73
- CART $9.57
- P/E Ratio
- NBIX $40.99
- CART $22.24
- Revenue Growth
- NBIX 18.42
- CART 10.47
- 52 Week Low
- NBIX $84.23
- CART $34.87
- 52 Week High
- NBIX $154.61
- CART $53.50
- Technical
- Relative Strength Index (RSI)
- NBIX 53.84
- CART 40.15
- Support Level
- NBIX $136.71
- CART $38.04
- Resistance Level
- NBIX $140.73
- CART $40.20
- Average True Range (ATR)
- NBIX 3.35
- CART 1.44
- MACD
- NBIX -0.34
- CART 0.22
- Stochastic Oscillator
- NBIX 72.66
- CART 70.64
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About CART Maplebear Inc.
Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The company partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart's ubiquitous platform. Once an item is ordered through Instacart's site, the item is picked and delivered to the customer's home by one of the platform's 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform's high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has about 8 million monthly active users (or orderers) on its platform.